These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 14760126)

  • 21. Phase II study of tolerance and efficacy of hyperfractionated radiotherapy and 5-fluorouracil, cisplatin, and paclitaxel (Taxol) in stage III and IV inoperable and/or unresectable head-and-neck squamous cell carcinoma: A-2 protocol.
    Abitbol A; Abdel-Wahab M; Lewin A; Troner M; Rodrigues MA; Hamilton-Nelson KL; Markoe A
    Int J Radiat Oncol Biol Phys; 2002 Jul; 53(4):942-7. PubMed ID: 12095561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cetuximab concomitant with gemcitabine and radiotherapy in advanced squamous cell carcinomas of upper aerodigestive tract: a pilot study.
    Granados García M; Chilaca Rosas MF; Lavín Lozano AJ; Maldonado Magos F; Frías Mendivil M; Cabrera Aquino G; Segura Pacheco BA; Montes Luis MM; Olvera Caraza D; Aguilar Ponce JL
    Clin Transl Oncol; 2011 Feb; 13(2):109-14. PubMed ID: 21324799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Long-term outcome of concurrent chemotherapy and reirradiation for recurrent and second primary head-and-neck squamous cell carcinoma.
    Salama JK; Vokes EE; Chmura SJ; Milano MT; Kao J; Stenson KM; Witt ME; Haraf DJ
    Int J Radiat Oncol Biol Phys; 2006 Feb; 64(2):382-91. PubMed ID: 16213104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
    Kohno N; Kitahara S; Tamura E; Tanabe T
    Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Radiochemotherapy with cisplatin and oral tegafur in advanced head and neck cancer: long-term results of a phase II study.
    de la Torre A; Romero J; Montero A; Garcia-Berrocal MI; Valcarcel FJ; Cordoba S; Magallon R
    Tumori; 2008; 94(4):453-8. PubMed ID: 18822677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase II trial of hyperfractionated intensity-modulated radiation therapy and concurrent weekly cisplatin for Stage III and IVa head-and-neck cancer.
    Maguire PD; Papagikos M; Hamann S; Neal C; Meyerson M; Hayes N; Ungaro P; Kotz K; Couch M; Pollock H; Tepper J
    Int J Radiat Oncol Biol Phys; 2011 Mar; 79(4):1081-8. PubMed ID: 20378262
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The evaluation of amifostine for mucosal protection in patients with advanced loco-regional squamous cell carcinomas of the head and neck (SCCHN) treated with concurrent weekly carboplatin, paclitaxel, and daily radiotherapy (RT).
    Suntharalingam M; Jaboin J; Taylor R; Wolf J; Banglore M; Van Echo D; Ord R
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):2-7. PubMed ID: 15726515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alternating gemcitabine and cisplatin with gemcitabine and radiation in stage IV squamous cell carcinoma of the head and neck.
    Benasso M; Corvò R; Ponzanelli A; Sanguineti G; Ricci I; Pallestrini E; Santelli A; Vitale V; Rosso R
    Ann Oncol; 2004 Apr; 15(4):646-52. PubMed ID: 15033674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapidly alternating chemotherapy and hyperfractionated radiotherapy in the management of locally advanced head and neck carcinoma: four-year results of a phase I/II study.
    Leyvraz S; Pasche P; Bauer J; Bernasconi S; Monnier P
    J Clin Oncol; 1994 Sep; 12(9):1876-85. PubMed ID: 8083711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Concurrent cisplatin/gemcitabine chemotherapy along with radiotherapy in locally advanced cervical carcinoma: a phase II trial.
    Umanzor J; Aguiluz M; Pineda C; Andrade S; Erazo M; Flores C; Santillana S
    Gynecol Oncol; 2006 Jan; 100(1):70-5. PubMed ID: 16288803
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction chemotherapy followed by concurrent chemoradiation in advanced squamous cell carcinoma of the head and neck: final results from a phase II study with docetaxel, cisplatin and 5-fluorouracil with a four-year follow-up.
    Rapidis AD; Trichas M; Stavrinidis E; Roupakia A; Ioannidou G; Kritselis G; Liossi P; Giannakouras G; Douzinas EE; Katsilieris I
    Oral Oncol; 2006 Aug; 42(7):675-84. PubMed ID: 16731029
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phase II trial of pemetrexed-based induction chemotherapy followed by concomitant chemoradiotherapy in previously irradiated patients with squamous cell carcinoma of the head and neck.
    Villaflor VM; Haraf D; Salama JK; Kocherginsky M; Langerman A; Gomez-Abuin G; Beniwal P; Blair EA; Stenson KM; Portugal L; Seiwert T; Williams RD; Dekker AJ; Witt ME; Vokes EE; Cohen EEW
    Ann Oncol; 2011 Nov; 22(11):2501-2507. PubMed ID: 21385883
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A phase II study of induction carboplatin and gemcitabine followed by chemoradiotherapy for the treatment of locally advanced nasopharyngeal carcinoma.
    Lim AM; Corry J; Collins M; Peters L; Hicks RJ; D'Costa I; Coleman A; Chua M; Solomon B; Rischin D
    Oral Oncol; 2013 May; 49(5):468-74. PubMed ID: 23369852
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
    Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
    Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.
    Numico G; Russi EG; Vitiello R; Sorrentino R; Colantonio I; Cipolat M; Taglianti RV; Pelissero A; Fea E; Granetto C; Di Costanzo G; Gasco M; Garrone O; Occelli M; Merlano M
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):731-7. PubMed ID: 17011449
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gemcitabine concurrent with thoracic radiotherapy after induction chemotherapy with gemcitabine/vinorelbine in locally advanced non-small cell lung cancer: a phase I study.
    Gagel B; Piroth M; Pinkawa M; Reinartz P; Zimny M; Fischedik K; Stanzel S; Breuer C; Skobel E; Asadpour B; Schmachtenberg A; Buell U; Eble MJ
    Strahlenther Onkol; 2006 May; 182(5):263-9. PubMed ID: 16673059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A phase II study of Gemcitabine (LY 188011) in patients with advanced squamous cell carcinoma of the head and neck. EORTC Early Clinical Trials Group.
    Catimel G; Vermorken JB; Clavel M; de Mulder P; Judson I; Sessa C; Piccart M; Bruntsch U; Verweij J; Wanders J
    Ann Oncol; 1994 Jul; 5(6):543-7. PubMed ID: 7918127
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Phase II Trial of Cisplatin, Gemcitabine, and Intensity-Modulated Radiation Therapy for Locally Advanced Vulvar Squamous Cell Carcinoma: NRG Oncology/GOG Study 279.
    Horowitz NS; Deng W; Peterson I; Mannel RS; Thompson S; Lokich E; Myers T; Hanjani P; O'Malley DM; Chung KY; Miller DS; Ueland FR; Dizon DS; Miller A; Mayadev JS; Leath CA; Monk BJ
    J Clin Oncol; 2024 Jun; 42(16):1914-1921. PubMed ID: 38574312
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of concomitant chemoradiation in locally advanced head and neck cancers.
    Lasrado S; Moras K; Pinto GJ; Bhat M; Hegde S; Sathian B; Luis NA
    Asian Pac J Cancer Prev; 2014; 15(10):4147-52. PubMed ID: 24935361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase I study of conformal radiotherapy with concurrent gemcitabine in locally advanced bladder cancer.
    Sangar VK; McBain CA; Lyons J; Ramani VA; Logue JP; Wylie JP; Clarke NW; Cowan RA
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):420-5. PubMed ID: 15667962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.